Display Settings:

Format

Send to:

Choose Destination

    J Natl Cancer Inst. 1990 Jul 4;82(13):1118-26.

    Two-year carcinogenicity study of sodium fluoride in rats.

    Maurer JK, Cheng MC, Boysen BG, Anderson RL.

    Procter and Gamble Co., Miami Valley Laboratories, Cincinnati, OH 45239-8707.

    Comment in:

    To determine the carcinogenic potential of sodium fluoride (NaF), we fed Sprague-Dawley rats a diet containing NaF for up to 99 weeks. Rats receiving NaF at a dose of 4, 10, or 25 mg/kg per day added to a low-fluoride diet were compared with controls receiving either a low-fluoride diet or laboratory chow. Each treatment group consisted of 70 rats of each sex. A 30% decrement in weight gain occurred at an NaF dose of 25 mg/kg per day. Evidence of fluoride toxicity was seen in the teeth, bones, and stomach, and the incidence and severity of these changes were related to the dose of NaF and the duration of exposure. Despite clear evidence of toxicity, NaF did not alter the incidence of preneoplastic and neoplastic lesions at any site in rats of either sex. Results from this study indicate that NaF is not carcinogenic in Sprague-Dawley rats.

    PMID: 2359138 [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Full Text Sources:

    Molecular Biology Databases:

    Supplemental Content

    Click here to read

    Patient drug information

    • Fluoride (ACT®, APF Gel®, Control Rx®, ...)

      Fluoride is used to prevent tooth decay. It is taken up by teeth and helps to strengthen teeth, resist acid, and block the cavity-forming action of bacteria. Fluoride usually is prescribed for children and adults whose h...